U.S. Wireless Telecom Stock News

NYSE:ANET
NYSE:ANETCommunications

Arista Networks (ANET) Is Up 10.2% After Highlighting Expanded AI Infrastructure Role With Hyperscalers

Arista Networks recently highlighted its role as an AI infrastructure provider to major hyperscalers like Microsoft and Meta, alongside new AI-focused platforms such as the R4 series and enhancements to its Arista AVA offering. This combination of deep hyperscaler relationships and AI-centric product rollouts has reinforced the view that Arista sits at the heart of cloud and AI data center buildouts. We'll now examine how Arista's expanding AI infrastructure offerings, particularly its R4...
NasdaqGM:PPIH
NasdaqGM:PPIHMachinery

Perma Pipe International Holdings (PPIH) Margin Compression To 6.9% Tests Bullish Narratives

Perma-Pipe International Holdings (PPIH) has reported another busy quarter, with Q3 2026 revenue of about US$61.1 million and basic EPS of US$0.78, alongside trailing 12 month revenue of roughly US$200.8 million and EPS of US$1.73 that frame the latest numbers in a wider context. Over recent periods the company has seen quarterly revenue move from US$44.99 million in Q4 2025 to US$46.75 million in Q1 2026, US$47.90 million in Q2 2026 and US$61.15 million in Q3 2026. Basic EPS tracked from...
NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

Assessing Chime Financial (CHYM) Valuation After Recent Share Price Momentum And Ongoing Losses

Recent share performance and business profile Without a specific news headline driving attention today, interest in Chime Financial (CHYM) centers on how its recent share performance and business profile line up with its current financial snapshot. Over the past week, the stock shows an 18.3% return, with a one-month gain of 19.1% and a decline of 10.2% over the past three months. Year to date, the return stands at an 11.3% decline. Chime Financial reports annual revenue of US$2.19b and a net...
NasdaqGS:NUVL
NasdaqGS:NUVLBiotechs

Does FDA Filing For Neladalkib’s ALK-Targeted Lung Cancer Therapy Change The Bull Case For Nuvalent (NUVL)?

Nuvalent, Inc. previously submitted a New Drug Application to the U.S. FDA for neladalkib, an investigational ALK-selective inhibitor, for TKI pre-treated patients with advanced ALK-positive non-small cell lung cancer based on Phase 1/2 ALKOVE-1 trial data. The filing builds on breakthrough therapy and orphan drug designations, underlining how neladalkib’s intracranial activity and TRK-sparing safety profile could address difficult-to-treat disease progression in this niche lung cancer...
NasdaqGS:QDEL
NasdaqGS:QDELMedical Equipment

QuidelOrtho (QDEL) Valuation Check After Weaker Q1 2026 Revenue Guidance And Sharply Negative Share Returns

QuidelOrtho (QDEL) recently issued preliminary Q1 2026 revenue guidance of US$615 million to US$620 million, citing weaker U.S. respiratory testing volumes, softer China distributor sales, and delayed EMEA orders linked to regional conflict. See our latest analysis for QuidelOrtho. Those headwinds have fed directly into sentiment, with a 1 day share price return of negative 27.47% and a 90 day share price return of negative 61.79%. The 1 year total shareholder return of negative 49.60% and 5...
NasdaqGS:CVLT
NasdaqGS:CVLTSoftware

Commvault AI Push And New Partners Meet Discounted Valuation And Mixed Track Record

Commvault Systems (NasdaqGS:CVLT) announced major expansions to its AI data protection capabilities and partner ecosystem. The company introduced new integrations with Hitachi Vantara and NetApp, extending Commvault Flex to key storage partners. Commvault rolled out advanced AI resilience features that support AI data governance, cyber recovery, and cloud-based workflow automation. Commvault Systems enters this product update cycle with a share price of $94.86 and a mixed recent track...
NYSE:HOMB
NYSE:HOMBBanks

Home BancShares (HOMB) Non Performing Loan Jump Tests Bullish Margin Stability Narrative

Home BancShares (HOMB) opened 2026 with Q1 results that sit against a trailing twelve month backdrop of US$1.1b in revenue and basic EPS of US$2.41 to the end of Q4 2025, paired with net income of US$475.4m. Over the last few reported quarters, revenue has stepped up from US$241.6m in Q4 2024 to US$267.7m in Q4 2025, while quarterly EPS moved from US$0.51 to US$0.60. This gives investors a clear revenue and earnings ramp to measure this latest update against. With net profit margins and the...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

MercadoLibre (NasdaqGS:MELI) Valuation Check After 45% Revenue Growth And Ongoing Investment

MercadoLibre (MELI) is back in focus after reporting 45% revenue growth, tied to growth initiatives such as lowering the free shipping threshold in Brazil and ongoing investment that has weighed on margins and recent EPS. See our latest analysis for MercadoLibre. At a share price of $1,822.13, MercadoLibre has seen a 5.44% 1 month share price return but is still facing a 7.68% year to date share price decline. The 3 year total shareholder return of 40.84% indicates that the longer term record...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Assessing Viavi Solutions (VIAV) Valuation After A Strong Multi Period Share Price Run

Event context and recent move Viavi Solutions (VIAV) has drawn fresh attention after a sharp rerating in recent months, with the share price moving alongside improving annual revenue and net income figures, even as the company remains loss making. See our latest analysis for Viavi Solutions. The latest 4.8% 1 day share price return sits within a strong run, with a 33.5% 30 day share price return and a very large 1 year total shareholder return suggesting momentum has been building over both...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

Align Technology’s Global Innovator Streak And What It Means For Valuation

Align Technology was named a Top 100 Global Innovator in the latest LexisNexis Innovation Momentum report. This is the fifth consecutive year the company has received this recognition. The ranking highlights Align Technology's emphasis on R&D and the strength of its global patent portfolio. Align Technology, listed on NasdaqGS:ALGN, sits at a share price of $185.02, with the stock up 6.0% over the past week and 5.1% over the past month. Returns of 18.6% year to date and 7.9% over the past...
NasdaqGS:HSAI
NasdaqGS:HSAIAuto Components

Is Hesai Group's (HSAI) Thoro.ai Partnership a Glimpse Into Its Robotics Platform Strategy?

Hesai Technology recently attended MODEX 2026 in Atlanta, where it showcased its JT128 mini 3D lidar and highlighted a collaboration to supply the sensor for Thoro.ai’s safety-certified AI autonomy platform in industrial and commercial robots. The partnership puts Hesai’s compact, ultra-wide field-of-view JT128 at the center of Thoro.ai’s CoreFlex architecture, aiming to simplify hardware integration and speed up deployment of autonomous mobile robots across cleaning and material-handling...
NYSE:KEY
NYSE:KEYBanks

KeyCorp (KEY) Net Interest Margin Near 3% Tests Bullish Earnings Recovery Narrative

KeyCorp (KEY) opened 2026 with Q1 results framed by its recent return to profitability, with trailing twelve month revenue at about US$7.0 billion and EPS of roughly US$1.53, giving investors a clearer picture of earnings power behind the current US$21.67 share price. Over the last few reported quarters, revenue has moved from US$816 million in Q4 2024 to US$1,889 million in Q4 2025, while quarterly EPS shifted from a loss of about US$0.28 to a profit of roughly US$0.43. This sets up a...
NasdaqGS:JBHT
NasdaqGS:JBHTTransportation

JB Hunt (JBHT) Margins Reach 5% Net Level Challenging Long Term Bearish Narratives

J.B. Hunt Transport Services (JBHT) has opened Q1 2026 earnings season with a recent run of quarterly revenue around US$3.0 billion and EPS climbing from US$1.18 in Q1 2025 to US$1.90 in Q4 2025, alongside trailing twelve month EPS of US$6.16. Over that same stretch, revenue has moved from US$2,921.4 million in Q1 2025 to US$3,096.6 million in Q4 2025, while trailing twelve month revenue has stayed close to US$12.0 billion. This has set the backdrop for margins that have edged higher and a...
NYSE:RACE
NYSE:RACEAuto

Is Ferrari (NYSE:RACE) Pricing Its Brand Too Highly After Recent Share Price Weakness

If you are wondering whether Ferrari's current share price reflects its quality, this breakdown will help you focus on what the numbers are really saying about value, not just the brand. The stock last closed at US$356.52, with returns of 1.2% over the past week, 6.0% over the past month, and a 4.1% decline year to date, while the 1 year return sits at an 18.3% decline versus longer term returns of 32.0% over 3 years and 72.1% over 5 years. Recent headlines around Ferrari have continued to...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

Is CSX’s (CSX) Intensified Track Maintenance Quietly Reframing Its Efficiency And Reliability Narrative?

CSX has recently undertaken extensive rail maintenance across several communities, including track upgrades on the Fitzgerald subdivision and work on dozens of crossings that temporarily closed key local roads. While these projects have caused short-term traffic disruptions, they underscore CSX’s ongoing focus on infrastructure reliability and safety as part of its core rail operations. With earnings approaching, we’ll explore how CSX’s stepped-up maintenance activity shapes the existing...
NasdaqGS:CEG
NasdaqGS:CEGElectric Utilities

Is It Too Late To Consider Constellation Energy (CEG) After Its 45% One Year Surge?

Investors may be asking whether Constellation Energy's current share price still makes sense after its strong run, or if expectations are running ahead of reality. The stock last closed at US$299.14, with returns of 6.7% over 7 days, a 2.8% decline over 30 days, an 18.3% decline year to date, and a 45.5% gain over 1 year. Taken together, this gives a mixed picture of recent momentum and risk sentiment. Recent coverage has focused on Constellation Energy's role in the utilities sector and how...
NYSE:BK
NYSE:BKCapital Markets

Bank Of New York Mellon Corporation (BK) Margin Strength Backs Bullish Narratives Heading Into Q1 2026

Bank of New York Mellon Corporation (BK) heads into Q1 2026 earnings season with solid recent numbers, having posted Q4 2025 revenue of US$5.1b, basic EPS of US$2.05 and trailing 12 month EPS of US$7.47 alongside net income of US$5.3b. Over the past year, revenue has moved from US$18.5b to US$20.0b on a trailing basis, while trailing net earnings grew 22.4% with margins stepping up from 23.5% to 26.5%. This gives investors a results set where profitability, rather than headline revenue...
NYSE:ET
NYSE:ETOil and Gas

How Energy Transfer’s Higher Payout and Data Center Gas Demand Will Impact Energy Transfer (ET) Investors

In early 2026, Energy Transfer raised its quarterly distribution to US$0.335 per unit (annualized US$1.34) and reaffirmed 2026 adjusted EBITDA guidance of US$17.45 billion to US$17.85 billion, backed by a multi‑billion‑dollar capital program. An interesting angle is how rising natural gas demand from data center customers is underpinning these steady distribution increases and long-term infrastructure investments. Next, we will examine how the higher distribution, underpinned by data...
NYSE:TALO
NYSE:TALOOil and Gas

A Look At Talos Energy (TALO) Valuation As Strait Of Hormuz Risks Lift Oil Prices

Why the Strait of Hormuz headlines matter for Talos Energy The prospect of a U.S. blockade at the Strait of Hormuz, a key oil shipping route, has pushed crude prices higher and quickly pulled offshore producer Talos Energy (TALO) into focus for investors. See our latest analysis for Talos Energy. Beyond the immediate oil price reaction, Talos Energy’s 90 day share price return of 29.7% and year to date share price return of 31.2% suggest that momentum has been building. In addition, the 1...
NYSE:DFH
NYSE:DFHConsumer Durables

Dream Finders Opens Tennessee 55 Plus Community And Broadens Reverie Strategy

Dream Finders Homes (NYSE:DFH) has opened Reverie at Parkhaven, its first Reverie active adult community in Tennessee. The project marks the company’s entry into the 55+ housing segment in the state. The opening expands DFH’s reach into both a new geography and a new age-targeted product category. Dream Finders Homes focuses on building single family homes and communities across multiple U.S. markets, and Reverie at Parkhaven adds a 55+ lifestyle concept to that portfolio. Active adult...
NasdaqGS:SBAC
NasdaqGS:SBACSpecialized REITs

A Look At SBA Communications (SBAC) Valuation As Shares Show Recent Momentum

SBA Communications (SBAC) has drawn fresh attention after a recent share price move, with the stock up 3.5% on the day and showing double digit gains over the past month. See our latest analysis for SBA Communications. The recent 1-day share price return of 3.53% and 30-day share price return of 18.49% at a latest share price of $221.76 come against a 1-year total shareholder return close to flat and weak 3 and 5 year total shareholder returns. This suggests momentum has only recently...
NYSE:KWR
NYSE:KWRChemicals

Quaker Chemical (KWR) Valuation Check After Mixed Recent Share Performance

Quaker Chemical stock triggered article Quaker Chemical (KWR) has drawn fresh attention after its recent share performance, with the stock showing a gain over the past month but a decline across the past 3 months and year to date. See our latest analysis for Quaker Chemical. Quaker Chemical’s recent 8.34% 1 month share price return contrasts with its 17.24% 3 month share price decline and weaker multi year total shareholder returns. This suggests momentum has cooled after a stronger 1 year...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

Is First-Line Darovasertib Combo Success in Uveal Melanoma Altering The Investment Case For IDEAYA Biosciences (IDYA)?

In April 2026, IDEAYA Biosciences and Servier reported that their darovasertib and crizotinib combination met the primary endpoint of improved progression-free survival in the Phase 2/3 OptimUM-02 trial for first-line HLA-A*02:01-negative metastatic uveal melanoma, outperforming current immunotherapy-based standard options. This is the first randomized study to show a statistically significant and clinically meaningful progression-free survival benefit in this hard-to-treat uveal melanoma...
NasdaqGS:TENB
NasdaqGS:TENBSoftware

Is Tenable (TENB) Turning OT Discovery Into a Durable Edge in Unified Cyber Exposure Management?

Earlier this month, Tenable Holdings, Inc. launched a VM‑Native OT Discovery engine that automatically uncovers OT, IoT and shadow IT assets, integrating cyber‑physical visibility directly into the Tenable One Exposure Management Platform without extra sensors, hardware or agents. The move highlights Tenable’s push to close long‑standing blind spots where IT networks meet cyber‑physical systems, giving customers a unified, low‑friction way to manage exposure across AI, IT, cloud, identity...